Advanced Biomed Inc Investment Income, Interest
Advanced Biomed Inc (ADVB) reported Investment Income, Interest of $9.21 thousand for the 3-month period ending 2025-12-31, per its 10-Q filed 2026-02-13.
Financial Statements › Income Statement › Other Income
us-gaap:InvestmentIncomeInterest · last filed 2026-02-13
- Advanced Biomed Inc investment income, interest for the quarter ending 2025-12-31 was $9.21K, a 40.13% decline year-over-year.
- Advanced Biomed Inc investment income, interest for the quarter ending 2025-09-30 was $448.00, a 4380.00% increase year-over-year.
- Advanced Biomed Inc investment income, interest for the quarter ending 2025-06-30 was $9.51K, a 71.53% decline year-over-year.
- Advanced Biomed Inc investment income, interest for the quarter ending 2025-03-31 was $26.00, a 75.00% decline year-over-year.
- Advanced Biomed Inc investment income, interest for fiscal 2025 was $24.91K, a 53.43% decline from fiscal 2024.
- Advanced Biomed Inc investment income, interest for fiscal 2024 was $53.49K.
| Period end | Investment Income, Interest 3 month | Investment Income, Interest 3 month as first filed | Investment Income, Interest 6 month | Investment Income, Interest 6 month as first filed | Investment Income, Interest 9 month | Investment Income, Interest 12 month |
|---|---|---|---|---|---|---|
| 2025-12-31 | $9.21K 10-Q · filed 2026-02-13 | $9.21K 10-Q · filed 2026-02-13 | $19.17K derived: sum of 3 quarters · filed 2026-02-13 | $19.19K derived: sum of 4 quarters · filed 2026-02-13 | ||
| 2025-09-30 | $448.00 10-Q · filed 2025-11-19 | $9.96K derived: sum of 2 quarters · filed 2025-11-19 | $9.99K derived: sum of 3 quarters · filed 2025-11-19 | $25.36K derived: sum of 4 quarters · filed 2026-02-13 | ||
| 2025-06-30 | $9.51K derived: 10-K 12 month − 10-Q 9 month · filed 2025-10-08 | $9.54K derived: sum of 2 quarters · filed 2025-10-08 | $24.91K derived: sum of 3 quarters · filed 2026-02-13 | $24.91K 10-K · filed 2025-10-08 | ||
| 2025-03-31 | $26.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-05-15 | $15.40K derived: sum of 2 quarters · filed 2026-02-13 | $15.40K 10-Q · filed 2025-05-15 | $48.82K derived: sum of 4 quarters · filed 2026-02-13 | ||
| 2024-12-31 | $15.38K 10-Q · filed 2026-02-13 | $15.42K 10-Q · filed 2025-04-15 | $15.38K 10-Q · filed 2026-02-13 | $15.43K 10-Q · filed 2025-04-15 | $48.80K derived: sum of 3 quarters · filed 2026-02-13 | $48.90K derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-09-30 | $10.00 10-Q · filed 2025-11-19 | $33.42K derived: sum of 2 quarters · filed 2025-11-19 | $33.52K derived: sum of 3 quarters · filed 2025-11-19 | $53.49K derived: sum of 4 quarters · filed 2025-11-19 | ||
| 2024-06-30 | $33.41K derived: 10-K 12 month − 10-Q 9 month · filed 2025-10-08 | $33.52K derived: sum of 2 quarters · filed 2025-10-08 | $53.48K derived: sum of 3 quarters · filed 2025-10-08 | $53.49K 10-K · filed 2025-10-08 | ||
| 2024-03-31 | $104.00 10-Q · filed 2025-05-15 | $20.07K derived: sum of 2 quarters · filed 2025-05-15 | $20.08K 10-Q · filed 2025-05-15 | |||
| 2023-12-31 | $19.97K 10-Q · filed 2025-04-15 | $19.98K 10-Q · filed 2025-04-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |